Hepatitis B Virus (HBV) remains a critical global health issue, impacting millions worldwide and frequently leading to severe liver diseases, including cirrhosis and liver cancer. For individuals with chronic HBV, comprehensive antiviral therapy is essential to lower viral loads, protect liver function, and improve long-term health outcomes. Entavir (Entecavir) has emerged as a cornerstone in HBV management, recognized for its effectiveness and widespread availability. India’s role as a leading producer and exporter of Entavir has been instrumental in meeting global demand and advancing public health initiatives.
Hepatitis B: A Persistent Global Health Challenge
